LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy

The constitutive activation of signal transducer and activator of transcription 3 (STAT3) is frequently detected in clinical incidences of hepatocellular carcinoma (HCC) but not in normal human hepatocytes. STAT3 signaling plays pivotal roles in angiogenesis, survival, metastasis, and growth of HCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Mingxin, Li, Chenglong, Lin, Jiayuh, Javle, Milind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484430/
https://www.ncbi.nlm.nih.gov/pubmed/25883212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484430/
https://www.ncbi.nlm.nih.gov/pubmed/25883212

Ejemplares similares